236 related articles for article (PubMed ID: 15668348)
1. Letter regarding article by Bokhari et al, "Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS)".
Boriani G; Biffi M; Martignani C
Circulation; 2005 Jan; 111(3):e26; author reply e26. PubMed ID: 15668348
[No Abstract] [Full Text] [Related]
2. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
[TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trials: how long should they last?
Wellens HJ
Circulation; 2004 Jul; 110(2):107-8. PubMed ID: 15249514
[No Abstract] [Full Text] [Related]
5. Cost-benefit analysis of preventing sudden cardiac deaths with an implantable cardioverter defibrillator versus amiodarone.
Caro JJ; Ward A; Deniz HB; O'Brien JA; Ehreth JL
Value Health; 2007; 10(1):13-22. PubMed ID: 17261112
[TBL] [Abstract][Full Text] [Related]
6. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
Della Bella P
Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
[No Abstract] [Full Text] [Related]
7. Are implantable cardioverter-defribrillators always superior to amiodarone?
Doggrell SA
Expert Opin Pharmacother; 2003 Nov; 4(11):2111-4. PubMed ID: 14596664
[TBL] [Abstract][Full Text] [Related]
8. Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs?
Ferrari R; Cinca J; Marber M
Eur Heart J; 1999 Mar; 20(6):397-8. PubMed ID: 10213339
[No Abstract] [Full Text] [Related]
9. Letter by Dardas and Aaronson regarding article, "Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial".
Dardas TF; Aaronson KD
Circulation; 2010 Oct; 122(15):e486; author reply e487. PubMed ID: 20937985
[No Abstract] [Full Text] [Related]
10. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.
Tung R; Zimetbaum P; Josephson ME
J Am Coll Cardiol; 2008 Sep; 52(14):1111-21. PubMed ID: 18804736
[TBL] [Abstract][Full Text] [Related]
11. Summaries for patients. Cost-effectiveness of implantable defibrillators versus the drug amiodarone to prevent abnormal heart rhythms after heart attack.
Ann Intern Med; 2001 Nov; 135(10):S-56. PubMed ID: 11757494
[No Abstract] [Full Text] [Related]
12. Management of cardiac arrest survivors: drugs or devices.
Madan N; Saksena S; Prakash A; Mathew PP
Indian Heart J; 1995; 47(4):387-93. PubMed ID: 8557286
[No Abstract] [Full Text] [Related]
13. Cost-benefit analysis of primary prevention of sudden cardiac death with an implantable cardioverter defibrillator versus amiodarone in Canada.
Deniz HB; Ward A; Jaime Caro J; Alvarez P; Sadri H
Curr Med Res Opin; 2009 Mar; 25(3):617-26. PubMed ID: 19232036
[TBL] [Abstract][Full Text] [Related]
14. Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.
Sanders GD; Hlatky MA; Every NR; McDonald KM; Heidenreich PA; Parsons LS; Owens DK
Ann Intern Med; 2001 Nov; 135(10):870-83. PubMed ID: 11712877
[TBL] [Abstract][Full Text] [Related]
15. Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy.
Cawley PJ; Al-Khatib SM
Am Heart J; 2004 May; 147(5):790-1. PubMed ID: 15131532
[No Abstract] [Full Text] [Related]
16. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
17. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.
Russo AM; Poole JE; Mark DB; Anderson J; Hellkamp AS; Lee KL; Johnson GW; Domanski M; Bardy GH
J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
Mark DB; Nelson CL; Anstrom KJ; Al-Khatib SM; Tsiatis AA; Cowper PA; Clapp-Channing NE; Davidson-Ray L; Poole JE; Johnson G; Anderson J; Lee KL; Bardy GH;
Circulation; 2006 Jul; 114(2):135-42. PubMed ID: 16818817
[TBL] [Abstract][Full Text] [Related]
19. Unresolved issues in implantable cardioverter-defibrillator therapy.
Mason PK; DiMarco JP
Cardiol Clin; 2008 Aug; 26(3):433-9, vii. PubMed ID: 18538189
[TBL] [Abstract][Full Text] [Related]
20. Subanalyses of secondary prevention implantable cardioverter-defibrillator trials: antiarrhythmics versus implantable defibrillators (AVID), Canadian Implantable Defibrillator Study (CIDS), and Cardiac Arrest Study Hamburg (CASH).
Oseroff O; Retyk E; Bochoeyer A
Curr Opin Cardiol; 2004 Jan; 19(1):26-30. PubMed ID: 14688631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
